The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate · BUTALBITAL 50 mg/1; ACETAMINOPHEN 325 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 · Capsule · Oral · Lgm Pharma Solutions, Llc
NDC 79739-6670-05 · 500 CAPSULE in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for butalbital, acetaminophen, caffeine and codeine phosphate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- LGM Pharma Solutions, LLCUnited Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- ANDA076560
- TE code
- AB
- Approval date
- Jun 10, 2004
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | BUTALBITAL 50 mg/1; ACETAMINOPHEN 300 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Aug 26, 2026 | Sep 3, 2026 |
| Actavis Pharma, Inc. | CODEINE PHOSPHATE 30 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1; ACETAMINOPHEN 325 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Lgm Pharma Solutions, Llc | BUTALBITAL 50 mg/1; ACETAMINOPHEN 325 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Actavis Pharma, Inc. | BUTALBITAL 300 mg/1; ACETAMINOPHEN 50 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Jul 22, 2026 | Aug 22, 2026 |
| Actavis Pharma, Inc. | CODEINE PHOSPHATE 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1; ACETAMINOPHEN 30 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Lgm Pharma Solutions, Llc | BUTALBITAL 325 mg/1; ACETAMINOPHEN 50 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Actavis Pharma, Inc. | ACETAMINOPHEN 300 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Jul 15, 2026 | Jul 16, 2026 |
| Actavis Pharma, Inc. | ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Lgm Pharma Solutions, Llc | ACETAMINOPHEN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1; CODEINE PHOSPHATE 30 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate — NDC 79739-6670-05," retrieved September 3, 2026, https://drugdashboards.com/drug/79739667005.
Free to cite with attribution — see how the data is put together.